|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.8 EUR | -0.13% |
|
+2.70% | +20.25% |
| May. 23 | FAES FARMA : Faes Farma is now receiving the long-awaited attention from investors |  |
| Apr. 26 | FAES FARMA : Q1 beat; full-year guidance re-affirmed | |
| Entry price | Target | Stop-loss | Potential |
|---|---|---|---|
| €3.71 | €4.6 | €3.44 | +24.16% |
● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The group's high margin levels account for strong profits.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
| 1st Jan change | Capi. | |
|---|---|---|
| +20.25% | 1.28B | |
| +40.73% | 739B | |
| +31.77% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +14.72% | 240B | |
| +9.52% | 210B | |
| -4.91% | 206B | |
| +6.17% | 164B |
FAES FARMA, S.A. 
